Skip to main content
Watch Insiders
LTRN filings

Corporate insider profile

D Jeffrey Keyser Filing Activity

Latest reported as Corporate insider of Lantern Pharma Inc. (LTRN).

Purchase filings
1
Reported companies
1
Net open-market value
$100,001
Latest transaction
May 12, 2026

Affiliated corporations

Reported company relationships

LTRNLatest reported

Lantern Pharma Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 12, 2026Lantern Pharma Inc. (LTRN)Corporate insiderOpen Market Purchase48,544$2.06$100,001